Perceptions and Representations of Vaccination Against COVID-19

NCT04896957 | Completed

• 1 other identifier: PERCECOVAC
• Study Type: observational
• Target: 14
• Locations: 1 country
• Sites: 1

Brief Summary

SARS COV2, the virus that causes COVID-19, was first described in Wuhan, China. For this pathology, which causes severe respiratory infections, preventing the transmission of the virus has become fundamental, that is why vaccines have been developed. In France, this vaccination campaign took place in a context where the lack of confidence in vaccination is high: According to a November 2020 IFOP poll, only 41% of French respondents were willing to be vaccinated against COVID-19. To our knowledge, there are still few qualitative studies on vaccination on the current issue of vaccination against COVID-19.

Conditions

COVID-19 Acute Respiratory Distress Syndrome

Keywords

vaccination perception

Outcome Measures

Primary Outcomes (1)

• Perceptions, representations and experiences of Covid-19 vaccination

  Interview based on 6 opened questions

  1 hour

Secondary Outcomes (1)

• Key elements to improve the medical discourse on vaccination

  1 hour

Interventions

Interview BEHAVIORAL

Face to face semi-directed interviews about perceptions, representations and experiences of Covid-19 vaccination, including six opened-questions

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients with or without comorbidities consulting the Villeneuve Saint Georges Hospital for COVID-19 vaccination or for a scheduled consultation

You may qualify if:

• Over 18 years of age
• Patient with a scheduled appointment in consultation or at the vaccination centre
• Not opposed to participation in the protocol

You may not qualify if:

• Patient under guardianship or curatorship
• Patient unable to give free and informed consent
• Patient under court protection
• Patient without the cognitive capacity to ensure an interview

Sponsors & Collaborators

• Centre Hospitalier Intercommunal Creteil: lead
• Centre Hospitalier Intercommunal Villeneuve Saint Georges: collaborator

Study Sites (1)

CHI Villeneuve-Saint-Georges

Villeneuve-Saint-Georges, France

Location

MeSH Terms

Interventions

Interviews as Topic

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 20, 2021
• First Posted: May 21, 2021
• Study Start: September 1, 2021
• Primary Completion: September 1, 2022
• Study Completion: September 1, 2022
• Last Updated: December 2, 2022

Record last verified: 2022-12

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)